Presbyosmia …

Douglas J Lanska MD MS MSPH

General Neurology

Updated 05.14.2024
Released 04.21.2013
Expires For CME 05.14.2027

Presbyosmia

Author: Douglas J Lanska MD MS MSPH

See Contributor Disclosures

Presbyosmia

In This Article

Quick Link

Introduction

Overview

In this article, the author explains the clinical presentation, pathophysiology, diagnostic workup, and management of presbyosmia. Presbyosmia (literally “elderly olfaction” or “old age olfaction”) is the gradual loss of olfactory abilities that occurs in most people as they grow older. Age-related losses of smell (presbyosmia) are common in the elderly and result from normal aging, certain diseases (especially Parkinson disease and dementia with Lewy bodies), medications, surgical interventions, and prior environmental exposures.

Key points

	• Presbyosmia (literally “elderly olfaction” or “old age olfaction”) is the gradual loss of olfactory abilities that occurs in most people as they grow older.
	• Clinically significant olfactory loss is common in the elderly but is frequently unrecognized, in part because deficits typically begin insidiously and accumulate gradually over decades.
	• Age-related losses of smell (presbyosmia) are common in the elderly and result from normal aging, certain diseases (especially Parkinson disease and dementia with Lewy bodies), medications, surgical interventions, and prior environmental exposures.
	• There is no established treatment for presbyosmia.

Historical note and terminology

Decreased smell is referred to as hyposmia, microsmia, or olfactory hypesthesia, whereas absent smell is referred to as anosmia (28). Presbyosmia (literally “elderly olfaction” or “old age olfaction”) is the gradual loss of olfactory abilities that occurs in most people as they grow older (28).

Clinical manifestations

Presentation and course

	• Clinically significant olfactory loss is common in the elderly but is frequently unrecognized, in part because deficits typically begin insidiously and accumulate gradually over decades.
	• Self-reported olfactory impairment significantly underestimates prevalence rates obtained by olfactory testing.
	• The elderly have higher olfactory thresholds, perceive suprathreshold odors less intensely, and are less able to discriminate odors or to recognize and identify common odors.
	• Because chemosensory impairment is so prevalent among the elderly, many elderly people complain that food lacks flavor (hypogeusia).

Clinically significant olfactory loss is common in the elderly, but is frequently unrecognized, in part because deficits typically begin insidiously and accumulate gradually over decades: indeed, self-reported olfactory impairment significantly underestimates prevalence rates obtained by olfactory testing (33; 28; 25).

There are major alterations of olfactory processing in advanced age with substantial losses in odor memory and odor identification performance (29). The elderly have higher olfactory thresholds, perceive suprathreshold odors less intensely, and are less able to discriminate odors or to recognize and identify common odors (02; 10). Age-related losses in olfaction are heterogeneous and are more likely to involve sensitivity to heavier molecules (47).

Because chemosensory impairment is so prevalent among the elderly, many elderly people complain that food lacks flavor (hypogeusia) (14). Loss of smell (hyposmia), distortions (dysosmia), and hallucinations (phantosmia) are common in the elderly; most distortions of smell resolve over time, although this may take years (12).

Olfactory impairment impacts quality of life for elderly individuals. Individuals with worse olfactory function are more likely to report loneliness (06). Olfactory dysfunction predicts subsequent development of depression in older adults in the United States (16). Olfactory impairment in older adults is associated with lower body weight and greater weight loss, decreased sexual motivation, and emotional satisfaction (40; 46).

Prognosis and complications

For patients with olfactory dysfunction, the prognosis depends primarily on etiology and the degree of residual function but also secondarily on gender, parosmia (distortion of the sense of smell), smoking habits, and age (20; 19). Male gender, initial presence of parosmia, smoking, and older age are negative prognostic factors (19; 39).

In some elderly patients, hyposmia may be an early ("preclinical") marker for the subsequent development of overt neurodegenerative disease. For example, impaired olfaction is associated with the later development of Parkinson disease and with increased likelihood of either incidental Lewy bodies or neuronal loss in the substantial nigra or locus coeruleus (11; 42).

Impaired olfaction adversely affects quality of life, psychological and physical health, and the enjoyment of eating, and it contributes to hypogeusia, impaired appetite, weight loss, frailty, and depression in elderly patients (21; 12). In addition, it may pose a safety risk as affected individuals may not smell smoke or gas leaks and are less likely to recognize that food has spoiled.

Biological basis

	• Age-related losses of smell (presbyosmia) are common in the elderly and result from normal aging, certain diseases (especially Alzheimer disease, Parkinson disease, and dementia with Lewy bodies), medications, surgical interventions, and prior environmental exposures, including tobacco use.
	• The majority of the age-related functional declines of the chemosenses are attributable to accumulated insults to the sensory system, smoking, medications, and comorbid disease.
	• Age-related loss of olfaction (presbycusis) does not share a common etiologic factor with age-related losses in other sensory modalities when assessed with objective measures.

Etiology and pathogenesis

Age-related losses of smell (presbyosmia) are common in the elderly and result from normal aging, certain diseases (especially Alzheimer disease, Parkinson disease, and dementia with Lewy bodies), medications, surgical interventions, and prior environmental exposures, including tobacco use (14; 12; 17; 18; 33; 26; 30; 28; 22).

The components of age-related losses of smell related to aging per se are relatively small (but significant), whereas most of the age-related functional declines of the chemosenses are attributable to accumulated insults to the sensory system, smoking, medications, and comorbid disease (20; 33; 26; 30).

Under normal conditions, adult stem cells reconstitute the olfactory neuroepithelium in response to cell loss. Aging-related inflammatory changes in stem cells of the olfactory epithelium may contribute to presbyosmia by disrupting normal epithelial homeostasis (36). Basal stem cells of the olfactory epithelium of presbyosmic individuals exhibit increased expression of genes involved in the response to cytokines, stress, or the regulation of proliferation and differentiation (36). In a culture model, cytokine exposure drove increased TP63, a transcription factor that prevents stem cell differentiation in the olfactory epithelium (36).

Part of the decline in olfactory abilities with age results from degeneration of the olfactory bulb: the number of mitral cells and glomeruli in the olfactory bulb decline markedly with age, at an approximate rate of 10% per decade, so that less than 30% of these elements remain by the ninth and tenth decades (32). Functional imaging shows significantly lower activation among the elderly in brain regions receiving primary olfactory projections (ie, piriform cortex, entorhinal cortex, and amygdala) (04).

In animal models, spatiotemporally restricted caspase activation occurs in neural structures required for olfaction (05). Caspase is activated in an age-dependent manner in specific subsets of olfactory receptor neurons and apparently plays a role in cell death regulation (05).

Age-related loss of olfaction (presbycusis) does not share a common etiologic factor with age-related losses in other sensory modalities when assessed with objective measures (03). Therefore, presbycusis is not associated with age-related losses in other sensory modalities (03). However, elderly individuals who experience a loss of smell may generalize this to their assessments of their functional abilities with other sensory modalities (03). Therefore, subjective measures should be combined with objective sensory threshold measurements when evaluating sensory dysfunction in the elderly (03).

Epidemiology

	• Olfactory senescence starts by the fifth decade and accelerates with advancing years, preferentially involving pleasant odors.
	• Smell identification ability declines markedly after the seventh decade: major olfactory impairment is present in about one third to one half of those aged 65 to 80 years and in some two thirds to four fifths of those over 80 years of age.
	• Factors associated with an increased prevalence of olfactory impairment in the elderly include race (ie, African American and Hispanic), male gender, current smoking, medications, medication polypharmacy, cumulative exposure to toxic fumes, prior head trauma, and comorbid conditions.

The prevalence of olfactory impairment increases with age. Olfactory senescence starts by the fifth decade and accelerates with advancing years, preferentially involving pleasant odors (14; 10; 39). Smell identification ability declines markedly after the seventh decade: major olfactory impairment is present in about one third to one half of those aged 65 to 80 years and in some two thirds to four fifths of those over 80 years of age (14; 08; 10; 33; 27).

In a Norwegian study of healthy adults, the proportion of hyposmia and anosmia measured with the Sniffin' Sticks test increased considerably with age (24). Men and participants with low education had poorer olfactory function scores. The lack of correlation between self-reported and measured olfactory function highlighted the importance of using validated tests (eg, the Sniffin' Sticks test or the PSIT) for an accurate olfactory evaluation.

Race (ie, African American and Hispanic), male gender, current smoking, medications, medication polypharmacy, cumulative exposure to toxic fumes, prior head trauma, comorbid conditions (eg, nasal congestion, upper respiratory tract infection, sinusitis, systemic viral illness, epilepsy, cerebrovascular disease, and neurodegenerative diseases), and lower education are associated with an increased prevalence of olfactory impairment in the elderly (44; 18; 33; 35; 34; 38; 39; 31; 37; 22; 48; 07). The relative resilience to age-related olfactory decline in women may be due to their profuse olfactory network connectivity (31).

In the US National Health and Nutrition Examination Survey (NHANES, 2013-2014), participants aged 70 to 80 years with vitamin D insufficiency (20 to 30 ng/mL) had a higher prevalence of smell and taste impairment (01). Vitamin D insufficiency may have a significant role in age-related smell impairment in adults aged 40 years or older and in age-related taste impairment in the elderly aged 70 to 80 years (01).

A cohort study of 2500 participants from the Health, Aging, and Body Composition Study followed subjects for 7 years after completing the 12-item Brief Smell Identification Test; this study found that poor olfaction is associated with a faster decline in mobility in older adults (50).

In the Health ABC study, 296 participants had data on both olfaction (measured using the 12-item Brief Smell Identification Test) and balance-related function (measured using the Romberg test); severe olfactory dysfunction was associated with increased odds of balance dysfunction, even when adjusting for age, gender, race, education, BMI, smoking, diabetes, depression, and dementia (49).

Olfactory status and decline over 5 years were studied in the Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study (45). The 12-item Sniffin’ Sticks odor identification test was used to assess olfaction in 6053 participants in 2011 to 2013 and in 3235 participants in 2016 to 2017. Older age, male sex, lower education, Black race, APOE ε4 alleles, and diabetes were associated with higher odor identification errors and higher anosmia prevalence, whereas greater physical activity and hypertension were associated with better olfaction. Older age, male sex, lower education, Black race, and APOE ε4 alleles were associated with elevated risk of incident anosmia over 5 years, whereas higher serum vitamin B12 levels were associated with lower risk of incident anosmia. Older age was associated with faster olfactory decline.

Odor identification response patterns were evaluated in an online study of a large, population-based sample of older adults in Sweden (n = 2479; age 60 to 100 years); odor identification tests reflect not only olfactory perception, but also likely involve the mental processing of odor-semantic associations, which may why these tests are useful in predicting dementia onset (41).

Differential diagnosis

Associated or underlying disorders

Disorders of olfaction in the elderly can be conveniently divided into conductive, sensorineural, and central disorders, where (1) conductive disorders involve transmission of the sensory stimuli to the sensory receptors (usually, but not always, by impeding transmission), (2) sensorineural disorders involve dysfunction of the sensory receptors or conduction of signals from the sensory receptors to the brain, and (3) central disorders involve dysfunction of processing of sensory information within the central nervous system, and particularly within the brainstem and cerebrum.

Conductive hyposmia (depending on the author or circumstance, “conductive” is sometimes stated conversely as “obstructive”) occurs if there are impediments to conveyance of odorants to the olfactory neuroepithelium (eg, upper respiratory infection, chronic rhinosinusitis, nasal polyposis). Sensorineural disorders involve the receptors themselves (“sensory”) or the afferent neural pathways involving the respective cranial nerves, tracts, or central processing centers of the brain (collectively “neural”). In addition to presbyosmia, other common causes of sensorineural hyposmia in the elderly include tobacco smoking, drug toxicity, head injury, hypothyroidism, and post-viral disorders (following an influenza-like infection). Common causes of central hyposmia in the elderly include Parkinson disease and dementia with Lewy bodies, but other neurodegenerative disorders are also associated with loss of smell. In general, conductive loss of olfaction is more likely to be remediable (ie, to result in significantly improved function) than is a sensorineural or central loss (43).

Diagnostic workup

	• Elderly patients with hyposmia should undergo a focused history and examination that addresses particularly the sense of smell, the nasal passages, and the nervous system.
	• Office testing of smell can include well-standardized, commercially available tests (eg, University of Pennsylvania Smell Identification Test or UPSIT) or crude approaches utilizing identification of a few readily available odorants (eg, oil of wintergreen, oil of cloves).
	• The UPSIT is a forced-choice olfactory discrimination test utilizing microencapsulated odorants in standardized "scratch 'n sniff” booklets.
	• A history of head trauma, past and current tobacco smoking, and medications should be reviewed for potential contributing causes to olfactory dysfunction.

Elderly patients with hyposmia should undergo a focused history and examination that addresses particularly the sense of smell, the nasal passages, and the nervous system. Office testing of smell can include well-standardized, commercially available tests (eg, University of Pennsylvania Smell Identification Test or UPSIT) or crude approaches utilizing identification of a few readily available odorants (eg, oil of Wintergreen, oil of cloves) (13; 15; 09). More complicated odor identification and detection tests are also available but are rarely practical outside of specialized diagnostic laboratories (09). The UPSIT is a forced-choice olfactory discrimination test utilizing micro-encapsulated odorants in standardized "scratch 'n sniff” booklets. UPSIT scores are standardized by gender and age and can be used to identify degrees of hyposmia and some malingerers. Irritant substances, such as ammonia, are sometimes employed when psychogenic or malingered anosmia is a consideration because such substances are perceived via trigeminal afferent pathways rather than through the olfactory system.

A history of head trauma, past and current tobacco smoking, and medications should be reviewed for potential contributing causes to olfactory dysfunction. Thyroid dysfunction should be excluded with thyroid-stimulation hormone (TSH) and free T4 assays. Patients with evidence of a conductive olfactory disturbance may warrant CT imaging of the paranasal sinuses or otolaryngologic referral or both. Patients with neurologic signs or symptoms need further evaluation to exclude neurodegenerative disorders and, rarely, structural lesions of the cribriform plate or basal forebrain. Neuroimaging is recommended in patients with dementia and in those with asymmetric or unilateral hyposmia not attributable to conductive hyposmia. Patients without conductive hyposmia and without evidence of neurologic signs of symptoms most likely have presbyosmia, although early neurologic disease is possible. Periodic re-examination may help identify cases of early neurodegenerative disease (eg, Alzheimer disease, Parkinson disease, dementia with Lewy bodies).

References

01: Bigman G. Age-related smell and taste impairments and vitamin D Associations in the U.S. Adults National Health and Nutrition Examination Survey. Nutrients 2020;12(4):984. PMID 32252288
02: Cain WS, Stevens JC. Uniformity of olfactory loss in aging. Ann N Y Acad Sci 1989;561:29-38. PMID 2735685
03: Cavazzana A, Röhrborn A, Garthus-Niegel S, Larsson M, Hummel T, Croy I. Sensory-specific impairment among older people. An investigation using both sensory thresholds and subjective measures across the five senses. PLoS One 2018;13(8):e0202969. PMID 30148857
04: Cerf-Ducastel B, Murphy C. FMRI brain activation in response to odors is reduced in primary olfactory areas of elderly subjects. Brain Res 2003;986(1-2):39-53. PMID 12965228
05: Chihara T, Kitabayashi A, Morimoto M, et al. Caspase inhibition in select olfactory neurons restores innate attraction behavior in aged Drosophila. PLoS Genet 2014;10(6):e1004437. PMID 24967585
06: Desiato VM, Soler ZM, Nguyen SA, et al. evaluating the relationship between olfactory function and loneliness in community-dwelling individuals: a cross-sectional study. Am J Rhinol Allergy 2021;35(3):334-40. PMID 32915652
07: Dong Y, Wang Y, Liu K, et al. Olfactory impairment among rural-dwelling chinese older adults: prevalence and associations with demographic, lifestyle, and clinical factors. Front Aging Neurosci 2021;13:621619. PMID 33912022
08: Doty RL. Olfactory capacities in aging and Alzheimer’s disease. Psychophysical and anatomic considerations. Ann N Y Acad Sci 1991;640:20-7. PMID 1776739
09: Doty RL. Office procedures for quantitative assessment of olfactory function. Am J Rhinol 2007;21(4):460-73. PMID 17882917
10: Doty RL. The Smell Identification Test Administration Manual. Haddon Heights, NJ: Sensonics, 2008.
11: Doty RL. Olfaction in Parkinson's disease and related disorders. Neurobiol Dis 2012;46(3):527-52. PMID 22192366
12: Doty RL. Age-related deficits in taste and smell. Otolaryngol Clin North Am 2018;51(4):815-25. PMID 30001793
13: Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984a;32(3):489-502. PMID 6463130
14: Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science 1984b;226(4681):1441-3. PMID 6505700
15: Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 1984c;94(2 Pt 1):176-8. PMID 6694486
16: Eliyan Y, Wroblewski KE, McClintock MK, Pinto JM. Olfactory dysfunction predicts the development of depression in older us adults. Chem Senses 2021;46:bjaa075. PMID 33197253
17: Elsner RJ. Odor threshold, recognition, discrimination and identification in centenarians. Arch Gerontol Geriatr 2001a;33(1):81-94. PMID 11461724
18: Elsner RJ. Environment and medication use influence olfactory abilities of older adults. J Nutr Health Aging 2001b;5(1):5-10. PMID 11250662
19: Hummel T, Lotsch J. Prognostic factors of olfactory dysfunction. Arch Otolaryngol Head Neck Surg 2010;136(4):347-51. PMID 20403850
20: Frye RE, Schwartz BS, Doty RL. Dose-related effects of cigarette smoking on olfactory function. JAMA 1990;263(9):1233-6. PMID 2304239
21: Gaines AD. Anosmia and hyposmia. Allergy Asthma Proc 2010;31(3):185-9. PMID 20615320
22: Glennon SG, Huedo-Medina T, Rawal S, Hoffman HJ, Litt MD, Duffy VB. Chronic cigarette smoking associates directly and indirectly with self-reported olfactory alterations: analysis of the 2011-2014 National Health and Nutrition Examination Survey. Nicotine Tob Res 2019;21(6):818-27. PMID 29121272
23: Goncalves S, Goldstein BJ. Pathophysiology of olfactory disorders and potential treatment strategies. Curr Otorhinolaryngol Rep 2016;4(2):115-21. PMID 27529054
24: Heian IT, Helvik AS, Hummel T, et al. Measured and self-reported olfactory function in voluntary Norwegian adults. Eur Arch Otorhinolaryngol 2022;279(10):4925-33. PMID 35195760
25: Ho IC, Chenoweth L, Williams A. Older people's experiences of living with, responding to and managing sensory loss. Healthcare (Basel) 2021;9(3):329. PMID 33803947
26: Kovacs T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res Rev 2004;3(2):215-32. PMID 15177056
27: Lafreniere D, Mann N. Anosmia: loss of smell in the elderly. Otolaryngol Clin North Am 2009;42(1):123-31. PMID 19134495
28: Lanska DJ. Disorders of the special senses in the elderly. In: Nair A, Sabbagh M, editors. Geriatric neurology. Chichester, West Sussex, UK: John Wiley & Sons, 2014: 396-459.
29: Lehrner JP, Gluck J, Laska M. Odor identification, consistency of label use, olfactory threshold and their relationships to odor memory over the human lifespan. Chem Senses 1999;24(3):337-46. PMID 10400452
30: Mackay-Sim A, Johnston AN, Owen C, Burne TH. Olfactory ability in the healthy population: reassessing presbyosmia. Chem Senses 2006;31(8):763-71. PMID 16901951
31: Martinez B, Karunanayaka P, Wang J, et al. Different patterns of age-related central olfactory decline in men and women as quantified by olfactory fMRI. Oncotarget 2017;8(45):79212-22. PMID 29108300
32: Meisami E, Mikhail L, Baim D, Bhatnagar KP. Human olfactory bulb: aging of glomeruli and mitral cells and a search for the accessory olfactory bulb. Ann N Y Acad Sci 1998;855:708-15. PMID 9929675
33: Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA 2002;288(18):2307-12. PMID 12425708
34: Nguyen-Khoa BA, Goehring EL Jr, Vendiola RM, Pezzullo JC, Jones JK. Epidemiologic study of smell disturbance in 2 medical insurance claims populations. Arch Otolaryngol Head Neck Surg 2007;133(8):748-57. PMID 17709610
35: Nordin S, Bramerson A, Bende M. Prevalence of self-reported poor odor detection sensitivity: the Skovde population-based study. Acta Otolaryngol 2004;124(10):1171-3. PMID 15768812
36: Oliva AD, Gupta R, Issa K, et al. Aging-related olfactory loss is associated with olfactory stem cell transcriptional alterations in humans. J Clin Invest 2022;132(4):e155506. PMID 34990409
37: Ottaviano G, Savietto E, Scarpa B, et al. Influence of number of drugs on olfaction in the elderly. Rhinology 2018;56(4):351-7. PMID 29938715
38: Pinto JM, Schumm LP, Wroblewski KE, Kern DW, McClintock MK. Racial disparities in olfactory loss among older adults in the United States. J Gerontol A Biol Sci Med Sci 2014;69(3):323-9. PMID 23689829
39: Pinto JM, Wroblewski KE, Kern DW, Schumm LP, McClintock MK. The rate of age-related olfactory decline among the general population of older U.S. adults. J Gerontol A Biol Sci Med Sci 2015;70(11):1435-41. PMID 26253908
40: Purdy F, Luo Z, Gardiner JC, et al. Olfaction and changes in body composition in a large cohort of older U.S. adults. J Gerontol A Biol Sci Med Sci 2020;75(12):2434-40. PMID 32267924
41: Raj R, Hörberg T, Lindroos R, et al. Odor identification errors reveal cognitive aspects of age-associated smell loss. Cognition 2023;236:105445. PMID 37027897
42: Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR. Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. Parkinsonism Relat Disord 2012;18 Suppl 1:S199-202. PMID 22166434
43: Seiden AM, Duncan HJ, Smith DV. Office management of taste and smell disorders. Otolaryngol Clin North Am 1992;25(4):817-35. PMID 1470441
44: Ship JA, Weiffenbach JM. Age, gender, medical treatment, and medication effects on smell identification. J Gerontol 1993;48(1):M26-32. PMID 8418141
45: Shrestha S, Zhu X, Kamath V, et al. Factors associated with poor olfaction and olfactory decline in older adults in the ARIC Neurocognitive Study. Nutrients 2023;15(16):3641. PMID 37630831
46: Siegel JK, Kung SY, Wroblewski KE, Kern DW, McClintock MK, Pinto JM. Olfaction is associated with sexual motivation and satisfaction in older men and women. J Sex Med 2021;18(2):295-302. PMID 33423973
47: Sinding C, Puschmann L, Hummel T. Is the age-related loss in olfactory sensitivity similar for light and heavy molecules? Chem Senses 2014;39(5):383-90. PMID 24803088
48: Stogbauer J, Wirkner K, Engel C, et al. Prevalence and risk factors of smell dysfunction - a comparison between five German population-based studies. Rhinology 2020;58(2):184-91. PMID 31693018
49: Yesantharao LV, Vohra V, Cheng M, et al. Olfactory dysfunction and balance dysfunction are associated with increased falls in older adults. Laryngoscope 2023;133(8):1964-9. PMID 37159236
50: Yuan Y, Chamberlin KW, Li C, et al. Olfaction and mobility in older adults. JAMA Otolaryngol Head Neck Surg 2024;150(3):201-8. PMID 38236595
51: Zhang C, Li D, Wang X. Role of physical exercise type in olfactory deterioration in ageing. Rhinology 2020;58(2):145-50. PMID 32249853

Patient Profile

Age range of presentation: 45 to 65+ years
Sex preponderance: Male>female, >1:1
Heredity: Heredity may be a factor
Population groups selectively affected: None selectively affected
Occupation groups selectively affected: None selectively affected

ICD & OMIM codes

ICD-10: Disturbances of smell and taste: R43

Anosmia: R43.0

Parosmia: R43.1
ICD-11: Disturbances of smell and taste: MB41

Anosmia: MB41.0

Parosmia: MB41.1

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Presbyosmia

Associated Disorders

Alzheimer disease
Dementia with Lewy bodies
Hypogeusia
Parkinson disease

Differential Diagnosis

Alzheimer disease
Conductive hyposmia
Dementia with Lewy bodies
Drug toxicity
Head injury
- Hypothyroidism
- Parkinson disease
- Post-viral disorders
- Tobacco smoking

Presbyosmia …

Presbyosmia

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Associated or underlying disorders

Diagnostic workup

Management

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Toxic and nutritional deficiency optic neuropathies

Third nerve palsy

Nystagmus

Brain death/death by neurologic criteria

Outpatient rehabilitation of chronic neurologic conditions

	• There is no established treatment for presbyosmia, and, in general, sensorineural and central causes of hyposmia are seldom correctable.
	• Smokers should be advised to quit smoking, and further counseling and pharmacologic management should be employed as necessary to facilitate cessation.
	• Patients should be counseled regarding safety issues and the use of proper monitoring devices for smoke and natural gas.

Presbyosmia

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Associated or underlying disorders

Diagnostic workup

Management

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Toxic and nutritional deficiency optic neuropathies

Third nerve palsy

Nystagmus

Brain death/death by neurologic criteria

Outpatient rehabilitation of chronic neurologic conditions

This is an article preview.
Start a Free Account
to access the full version.